DIPEPTIDYL-PEPTIDASE-4 (DPP4) IS A POTENTIAL NEW MOLECULAR TARGET FOR TREATMENT OF FIBROSIS

Soare AM, Gyoerfy H, Matei AE, Dees C, Zhang Y, Wohlfahrt T, Chen CW, Ramming A, Schett G, Distler J (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 77

Pages Range: 735-736

DOI: 10.1136/annrheumdis-2018-eular.7182

Authors with CRIS profile

Alexandru-Emil Matei Department of Medicine 3 – Rheumatology and Immunology Clara Dees Department of Medicine 3 – Rheumatology and Immunology Yun Zhang Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

How to cite

APA:

Soare, A.M., Gyoerfy, H., Matei, A.-E., Dees, C., Zhang, Y., Wohlfahrt, T.,... Distler, J. (2018). DIPEPTIDYL-PEPTIDASE-4 (DPP4) IS A POTENTIAL NEW MOLECULAR TARGET FOR TREATMENT OF FIBROSIS. (pp. 735-736).

MLA:

Soare, A. M., et al. "DIPEPTIDYL-PEPTIDASE-4 (DPP4) IS A POTENTIAL NEW MOLECULAR TARGET FOR TREATMENT OF FIBROSIS." 2018. 735-736.

BibTeX: Download